Meletios A. Dimopoulos

Meletios A. Dimopoulos, MD, is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. In February 2015 he was elected Rector of the National and Kapodistrian University of Athens until August 2023. In March 2013 Dr. Dimopoulos was elected as a member of the Board of the International Myeloma Society. Currently he is the chairman of the Greek Myeloma Study Group and of the Balkan Myeloma Study Group.

He is a recipient of the Robert A. Kyle Award for outstanding contributions to Waldenstrom’s macroglobulinemia (May 2003), a recipient of Waldenstrom’s award for Myeloma Research of the International Myeloma Society (March 2017), recipient of the CoMy Excellence Award (May 2017) and of the Robert Kyle Life Achievement Award (June 2019).

MEDtalks

Daratumumab Monotherapy Shows Clinical Benefit for Early Intervention for Patients with High-Risk Smoldering Multiple Myeloma

December 2024 / Meletios A. Dimopoulos

ASH24 Myeloma

Multiple Myeloma: Belantamab Mafodotin plus Pomalidomide and Dexamethasone Show Significant Higher PFS, Deep Response and OS vs Those of Standard of Care

June 2024 / Meletios A. Dimopoulos

EHA24 Myelooma 04:07

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.